Cargando…
Hilar lymphadenopathy, development of tubulointerstitial nephritis, and dense deposit disease following Pfizer-BioNTech COVID-19 vaccination
Despite the reports on glomerulonephritis associated with COVID-19 mRNA vaccines, no study has reported about the dense deposit disease (DDD). Here, we present a case of hilar lymphadenopathy after the COVID-19 mRNA vaccination, following which the patient developed tubulointerstitial nephritis (TIN...
Autores principales: | Nakamura, Hironori, Ueda, Michiko, Anayama, Mariko, Makino, Mutsuki, Makino, Yasushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747079/ https://www.ncbi.nlm.nih.gov/pubmed/36513952 http://dx.doi.org/10.1007/s13730-022-00762-7 |
Ejemplares similares
-
COVID-19-Vaccine-Pfizer-BioNTech: Mediastinal lymphadenopathy: case report
Publicado: (2021) -
Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19
Vaccination: MRI Evaluation
por: Yoshikawa, Takeharu, et al.
Publicado: (2022) -
A case of acute interstitial nephritis following the Pfizer–BioNTech COVID-19 vaccine
por: de la Flor Merino, José Carlos, et al.
Publicado: (2022) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021) -
Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021)